1. Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects. Issue 4 (2nd December 2019) Authors: Flanagan, Shawn; Goodman, Daniel B.; Jandourek, Alena; O'Reilly, Terry; Sandison, Taylor Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 4(2020) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial. Issue 3 (July 2019) Authors: Nyirjesy, Paul; Alessio, Cynthia; Jandourek, Alena; Lee, Jon D.; Sandison, Taylor; Sobel, Jack D. Journal: Journal of lower genital tract disease Issue: Volume 23:Issue 3(2019:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 268Clinical Response of Tedizolid vs Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure: Pooled Analysis of 2 Phase 3 Double-Blind Trials. (December 2014) Authors: Sandison, Taylor; De Anda, Carisa; Fang, Edward; Das, Anita; Prokocimer, Philippe Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial. (21st September 2020) Authors: Thompson, George R; Soriano, Alex; Skoutelis, Athanasios; Vazquez, Jose A; Honore, Patrick M; Horcajada, Juan P; Spapen, Herbert; Bassetti, Matteo; Ostrosky-Zeichner, Luis; Das, Anita F; Viani, Rolando M; Sandison, Taylor; Pappas, Peter G Journal: Clinical infectious diseases Issue: Volume 73:Number 11(2021) Page Start: e3647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin. (4th December 2021) Authors: Huguet, Jade; Ong, Voon; Sandison, Taylor; Melara, Rebeca M; Marbury, Thomas C; Jandourek, Alena; Flanagan, Shawn Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 262Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2 Studies. (December 2014) Authors: Sandison, Taylor; De Anda, Carisa; Das, Anita; Prokocimer, Philippe Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects. Issue 7 (4th May 2022) Authors: Gu, Kenan; Ruff, Dennis; Key, Cassandra; Thompson, Marissa; Jiang, Shoshanna; Sandison, Taylor; Flanagan, Shawn Journal: Clinical and translational science Issue: Volume 15:Issue 7(2022) Page Start: 1592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study. (26th November 2018) Authors: Thompson, George R; Vazquez, Jose; Soriano, Alex; Skoutelis, Athanasios; Ostrosky-Zeichner, Luis; Mena, Karen; Navalta, Laura; Sandison, Taylor; Pappas, Peter Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2389. Effect of Rezafungin on QT Interval in Healthy Subjects. (26th November 2018) Authors: Flanagan, Shawn; Goodman, Daniel B; Rao, Pallavi; Jandourek, Alena; O'Reilly, Terry; Sandison, Taylor Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 1390. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Rezafungin (RZF) Dose Selection in Treatment of Candida. (26th November 2018) Authors: Lakota, Elizabeth A; Ganesan, Harish; Flanagan, Shawn; Ong, Voon; Sandison, Taylor; Bhavnani, Sujata M; Rubino, Christopher M; Ambrose, Paul G Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗